Stand aside — setup invalidated
Setup score 97, but distribution days reach 5 or more — stand aside until the condition resets.
Simple research view
ABBV · AbbVie Inc.
$286.74 +0.39% Oct 26 close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$ABBV
AbbVie Inc.AbbVie Inc. is a mega-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $507B.
Market Structure
Trend structure: uptrend
Latest event: structure_shift
(bullish)
Support
219.60–221.12
· 5 touches · strong
Support
229.65–230.94
· 4 touches · moderate
Support
226.86–228.40
· 4 touches · moderate
Support
237.04–238.15
· 3 touches · moderate
Support
223.02–223.23
· 3 touches · moderate
Verdict · setup score 97/100 · data Oct 26 close · latest session
Stand aside — setup invalidated
Setup score 97, but distribution days reach 5 or more — stand aside until the condition resets.
Recent price action · daily
What would change this verdict
What needs to turn for this to become buyable — the top failing checks across the legend council:
- Minervini 2. Revenue growth ≥ 20% YoY — +8.6% YoY
- O'Neil M: Market in confirmed uptrend — Market phase: uptrend_under_pressure
- O'Neil S: Volume ≥ 40% above average on breakout
- Weinstein Volume expansion above average — Volume ratio 0.97x
- Dennis S1: 20-day Donchian breakout
- Dennis S2: 55-day Donchian breakout
Minority view — the council disagrees here
- Minervini: watch Trend-template read: 9/10 pass; wait for the soft misses to improve.
- O'Neil: watch CANSLIM read: 5/8 pass; improvement is still needed.
- Weinstein: watch Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
69
Strong
Legend Score · rates the stock
Strong (69/100) — held back by eps growth
Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.
- Relative Strength (25%) 85
- Trend Template (25%) 100
- Institutional Footprint (20%) 68
- EPS Growth (15%) 31
- Quality (SMR-like) (15%) 33
RS rank 84: beating most of the market. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 68: mild accumulation. EPS up +0% — growing, but below the 25% leadership bar. Quality 33: weak fundamentals (sales growth 30, return on equity 44, leverage 20). Updated 2026-10-27.
Earnings
Post-earnings setup
Next earnings
Friday, October 23, 2026
Report time not confirmed by the source
Deterministic evidence
ABBV+0.39%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
CatalystUnavailable
Stock reactionPositive
Sector reactionWeak
Opening surge—
Event riskEarnings-driven
Session internals Mixed
Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.
Vs prior close+0.39%
From the open-0.23%
Range position35%
GapNo gap
QQQ confirmationConfirming (+1.11%)
SMH confirmationConfirming (+2.74%)
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$190.75
Tight Wks
1
Base
B1
SMA 200
$235.72
RS Line vs High
-0.3%
RS Line Slope
+8.7% ▲
Group Rank
#12/66
ADR%
2.4%
ATR(14)
$6.99 (2.4%)
Vol Pace (live)
N/A
A/D Days
17A / 12D
A/D Rating
A+
VDU Bars
0/10 d
Power Trend
17d
Earnings
in 2d
ABBV Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$ABBV · $286.74 · as of 2026-10-26 · multi-factor read
100
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▲ Uptrend
Weekly
▲ Uptrend
Monthly
▲ Uptrend
Moving Averages
50-day$266.87 ↑
100-day$255.66 ↑
200-day$235.72 ↑
Bullish (50 > 200)
RSI (14)
Reading66.2 · Bullish
Bullish momentum — comfortably in buyer territory.
MACD (12/26/9)
StateBullish
Histogram+0.513
Bullish — MACD above its signal line and above zero. Histogram contracting.
Bollinger Bands (20,2)
%B / Width77% · 14.3%
Mid-band — no directional band edge in play.
Volume · Buyer vs Seller
Up/Down vol1.42 · Neutral
Rel volume0.97×
Pocket pivots · 10d0
5d vs 50d vol108%
Heavy vol up / down1 / 1
Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.
- 1 heavy-volume up day vs 1 down in the last 20 sessions.
Support & Resistance
R · $291.4052-week high
Price · $286.74now
S · $257.87swing level
S · $246.77swing level
S · $242.13swing level
Fibonacci · Uptrend swing
23.6%$269.83
38.2%$256.49
50.0%$245.71
61.8%$234.93
78.6%$219.58
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ABBV — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 84 (leader)
Want this read in a legend's voice?
Ask a Legend about ABBV
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (97/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.
Council consensus:
8 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini
Watch
A
Trend-template read: 9/10 pass; wait for the soft misses to improve.
partialMonitor Trend Only for tighter volatility contraction before entry. SEPA Grade A (6/7).
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $286.74, MA150 $240.05, MA200 $235.72
1.2 150-day MA > 200-day MAMA150 $240.05 vs MA200 $235.72
Failing evidence
2. Revenue growth ≥ 20% YoY+8.6% YoY
O'Neil
Watch
C
CANSLIM read: 5/8 pass; improvement is still needed.
Passing evidence
C: Quarterly EPS acceleration ≥ 25%+37.7% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 84
Failing evidence
M: Market in confirmed uptrendMarket phase: uptrend_under_pressure
S: Volume ≥ 40% above average on breakoutNot confirmed
Weinstein
Watch
B
Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $286.74 vs MA200 $235.72
Failing evidence
Volume expansion above averageVolume ratio 0.97x
dennis
Watch
C
Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $257.87
Volatility-unit sizing (1N ≈ 1% of equity)1N = $6.20 (2.16% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
zanger
Avoid
D
Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $329.75-$344.09; trail the rest
Trail on the 10/20-day MA10-day MA $284.08 · 20-day MA $276.11 — exit the remainder on a close below the trail
Failing evidence
Named Zanger pattern onlyTrend Only is not one of Zanger's six
Not extended (≤5% above the breakout point)Data unavailable
zweig
Watch
D
Zweig read: part of his screen passes but not all: Reasonable price for the growth (P/E ≤ 35); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
EPS growth above the market (≥15% QoQ)+37.7% QoQ — Zweig wants growth above the S&P average
Price strength (RS ≥ 70)RS score 84 — Zweig buys strength, not bargains
Failing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 121.5x — no PEG or forward P/E stored
Insider buyingNo insider buying flagged
Livermore
Watch
B
Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$286.74
Relative strengthRS 84
Failing evidence
Volume vs average0.97x
Pivotal point cleared on expanding volumeNot confirmed
Darvas
Watch
B
Box-theory read: constructive evidence is present, but volume vs average is unresolved.
mediumStock is at the top of its box — Darvas would wait for a decisive breakout on volume.
Passing evidence
Price$286.74
Relative strengthRS 84
Failing evidence
Volume vs average0.97x
Box top broken on heavy volumeNot confirmed
Wyckoff
Watch
B
Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$286.74
Relative strengthRS 84
Failing evidence
Volume vs average0.97x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
NH
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +9
Fundamentals & leadership quality — Minervini’s published criteria · 6/7 met
A
6/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+38%
Revenue growth ≥20% YoY
+9%
Gross margin ≥30%
73%
ROE ≥17%
96%
RS rating ≥80 (leadership)
84
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-1.6%
Method Playbook
Trade it like Wyckoff
EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis
97
setup score
RS Score
84
Trend template
8/8 ✓
Why This Setup?
D+W Confluence
Trend Only · schematic
Gatekeeper 8/8 | Strong trend (8/8) | Top RS (84) | RS at new high | Power Trend | Stage 2
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
1/7
universals met
- Clear of earnings — not met in 2 days — event risk
- Risk is defined — not met No stop — undefined risk
- A relative-strength leader — partly met RS rank 66 — middling
- Asymmetric reward — partly met No target set
- Not chasing (in range) — partly met Pivot distance unknown
- Volume confirms — partly met 1.0× average — light
- In a confirmed uptrend — met Stage 2 · Trend template 8/8
Minervini Trend Template
8/8 ✓Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$286.74 vs SMA150 $240.05 / SMA200 $235.72
SMA 150 above SMA 200
SMA150 $240.05 vs SMA200 $235.72
SMA 200 trending up
Slope +4.94 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $266.87
Price above SMA 50
$286.74 vs SMA50 $266.87
30%+ above 52-week low
+50.3% from $190.75
Within 25% of 52-week high
-1.6% from $291.40
RS score above 70
RS 84
Fundamentals
52W Range
95%
Mkt Cap SEC
506.7B
EPS QoQ
+38%
Rev YoY
+9%
ROE
96%
Gross Margin
73%
D/E
20.19
EPS TTM
$2.36
P/E TTM
121.5x
Float
1.8B
Insider
No Buy
Company
Company profile
AbbVie Inc.
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
8/8
W. RS
85
W. Support
$190.75
W. Resist
$291.40
W. Patterns
Cup & Handle
Weekly Structure
Trend
Neutral
Tight Weeks
1
Confirmation
Neutral
Scan History
20× streakOct 27
Trend Only
✓ Gate
97
Oct 27
Trend Only
✓ Gate
95
Oct 26
Trend Only
✓ Gate
97
0.0%
Oct 26
Trend Only
✓ Gate
96
0.0%
Oct 23
Trend Only
✓ Gate
91
+0.4%
Latest News
Headlines for ABBVLoading headlines…
Get the full picture on ABBV
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial